Numenor Ventures
Numenor Ventures is a venture capital firm founded in 2002, specializing in seed and early-stage investments. It focuses on life sciences, technology, unique consumer products, fine art, and real estate opportunities, primarily in California, Colorado, Nevada, and the Pacific Northwest. The firm typically takes a board seat in its portfolio companies and offers advisory services.
Top Stages
2 past transactions
AnaptysBio
Series B in 2007
AnaptysBio is a clinical-stage biotechnology company focused on developing therapeutic antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company's pipeline includes immune cell modulating antibodies such as rosnilimab, a PD-1 agonist in Phase 2b trials for rheumatoid arthritis and ulcerative colitis, and ANB032, a BTLA agonist in Phase 2b trial for atopic dermatitis.
Nutricate
Series A in 2007
Nutricate is a product of SmartReceipt that prints nutritional information on customer receipts, personalized to their specific order. It offers percentage of daily values as well as nutritional facts and suggestions to improve customer health.
Nutricate's parent company, Mobivity, is based in Chandler, AZ.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.